Logo image of LZMH

LZ TECHNOLOGY HDS LTD -CL B (LZMH) Stock Fundamental Analysis

NASDAQ:LZMH - Nasdaq - KYG57Y3D1093 - Common Stock - Currency: USD

12.98  -0.09 (-0.69%)

Fundamental Rating

2

LZMH gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 96 industry peers in the Media industry. While LZMH seems to be doing ok healthwise, there are quite some concerns on its profitability. LZMH is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year LZMH has reported negative net income.
LZMH had a negative operating cash flow in the past year.
LZMH Yearly Net Income VS EBIT VS OCF VS FCFLZMH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 -20M -40M -60M

1.2 Ratios

LZMH has a Return On Assets (-2.17%) which is in line with its industry peers.
With a Return On Equity value of -10.79%, LZMH perfoms like the industry average, outperforming 42.71% of the companies in the same industry.
Industry RankSector Rank
ROA -2.17%
ROE -10.79%
ROIC N/A
ROA(3y)-15.13%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LZMH Yearly ROA, ROE, ROICLZMH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 50 -50 100 150

1.3 Margins

The Gross Margin of LZMH (5.49%) is worse than 81.25% of its industry peers.
LZMH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LZMH Yearly Profit, Operating, Gross MarginsLZMH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 -20 -40

4

2. Health

2.1 Basic Checks

LZMH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LZMH has about the same amount of shares outstanding.
Compared to 1 year ago, LZMH has an improved debt to assets ratio.
LZMH Yearly Shares OutstandingLZMH Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 50M 100M 150M
LZMH Yearly Total Debt VS Total AssetsLZMH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 33.29 indicates that LZMH is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 33.29, LZMH belongs to the top of the industry, outperforming 98.96% of the companies in the same industry.
LZMH has a Debt/Equity ratio of 0.52. This is a neutral value indicating LZMH is somewhat dependend on debt financing.
The Debt to Equity ratio of LZMH (0.52) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Altman-Z 33.29
ROIC/WACCN/A
WACC7.52%
LZMH Yearly LT Debt VS Equity VS FCFLZMH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M -20M 40M -40M -60M

2.3 Liquidity

LZMH has a Current Ratio of 1.15. This is a normal value and indicates that LZMH is financially healthy and should not expect problems in meeting its short term obligations.
LZMH has a Current ratio of 1.15. This is comparable to the rest of the industry: LZMH outperforms 41.67% of its industry peers.
LZMH has a Quick Ratio of 1.15. This is a normal value and indicates that LZMH is financially healthy and should not expect problems in meeting its short term obligations.
LZMH has a Quick ratio (1.15) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 1.15
LZMH Yearly Current Assets VS Current LiabilitesLZMH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 50M 100M 150M 200M 250M

1

3. Growth

3.1 Past

LZMH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.51%, which is quite impressive.
The Revenue has grown by 249.10% in the past year. This is a very strong growth!
EPS 1Y (TTM)54.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.51%
Revenue 1Y (TTM)249.1%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%249.1%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LZMH Yearly Revenue VS EstimatesLZMH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 100M 200M 300M 400M 500M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LZMH. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LZMH Price Earnings VS Forward Price EarningsLZMH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

LZMH's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. LZMH is more expensive than 69.79% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3301.67
LZMH Per share dataLZMH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for LZMH!.
Industry RankSector Rank
Dividend Yield N/A

LZ TECHNOLOGY HDS LTD -CL B

NASDAQ:LZMH (5/21/2025, 4:30:01 PM)

12.98

-0.09 (-0.69%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.68B
AnalystsN/A
Price TargetN/A
Short Float %7.02%
Short Ratio0.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 21.3
P/FCF N/A
P/OCF N/A
P/B 210.53
P/tB 222.44
EV/EBITDA 3301.67
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.61
BVpS0.06
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.17%
ROE -10.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.49%
FCFM N/A
ROA(3y)-15.13%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.99
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Debt/EBITDA 8.13
Cap/Depr 1.1%
Cap/Sales 0.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.15
Quick Ratio 1.15
Altman-Z 33.29
F-Score4
WACC7.52%
ROIC/WACCN/A
Cap/Depr(3y)244.43%
Cap/Depr(5y)N/A
Cap/Sales(3y)12.54%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.51%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)249.1%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%249.1%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y70.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-355.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-777.55%
OCF growth 3YN/A
OCF growth 5YN/A